1. United Kingdom Stocks

  2. •

    Basic Materials

  3. •

    Chemicals - Specialty
Iofina plc

Iofina plc

IOFNF
Iofina plcUS flagOther OTC
0.65
USD
+0.04
- -
125.55MMarket Cap
Iofina plc
IOFNF
(Other OTC)

Recent

price

0.65

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
0.13
0.14
0.15
0.15
0.2
0.16
0.17
0.16
0.19
0.18
0.15
0.2
0.22
0.26
0.28
0.35
Revenue per Share
-0.05
-0.02
-0.01
-0.03
-0.05
-0.02
-0.03
-0.08
-0.01
- -
0.01
0.05
0.04
0.03
0.02
0.04
Basic EPS, GAAP
-0.04
-0.03
-0.07
-0.1
-0.05
-0.01
- -
-0.02
0.01
0.01
0.01
0.03
0.01
0.01
0.01
0.01
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.09
-0.1
-0.1
-0.13
-0.18
-0.2
-0.22
-0.29
-0.3
-0.23
-0.19
-0.14
-0.1
-0.06
-0.05
0.31
Book Value per Share
0.13
0.17
0.18
0.18
0.14
0.12
0.09
0.02
0.01
0.09
0.09
0.14
0.18
0.22
0.23
0.27
Tangible Book Value per Share
107
113
124
129
129
129
129
129
129
163
192
192
192
192
192
192
Basic Weighted Avg Shares
14
16
19
19
26
20
22
21
24
29
30
39
42
50
54
67
Sales/Revenue/Turnover
-37.53
-17.59
-7.38
-16.13
-10.58
-7.73
-14.76
-3.26
4.45
9.53
9.73
13.3
22.78
17.26
9.06
13.03
Operating Margin (%)
1
2
1
1
2
2
2
2
2
2
2
2
2
2
3
3
Depreciation Expense
-5
-3
-1
-4
-7
-3
-4
-10
-1
1
1
9
8
7
3
8
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
21.59
21.05
39.2
25.25
Effective Tax Rate (%)
-37.57
-16.44
-6.07
-19.78
-25.72
-14.64
-16.29
-46.74
-4.77
1.89
4.3
23.53
18.64
13.12
5.36
11.83
Profit Margin (%)
8
9
13
14
11
9
6
8
10
-2
9
10
18
21
16
24
Working Capital
- -
- -
- -
15
19
19
16
22
25
- -
11
7
6
4
3
5
LT Debt
24
26
31
29
23
21
17
7
6
19
21
30
38
45
48
56
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
8.14
8.03
- -
17.98
14.24
5.85
11.33
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
-18.28
-11.5
- -
-54.44
-74.77
-52.98
26.67
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
25.13%
22.59%
16.51%
Free Cash Flow
70.46%
66.7%
31.22%
Net Income, GAAP
78.55%
140.39%
169.64%
Sales/Revenue/Turnover
13.1%
17.83%
22.12%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
50
2024
- -
- -
- -
- -
54
2025
- -
- -
- -
- -
67

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.03
2024
- -
- -
- -
- -
0.02
2025
- -
- -
- -
- -
0.04

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Similar Companies
New Japan Chemical Co., Ltd. (4406.T)
Jiangsu Jiuding New Material Co., Ltd. (002201.SZ)
Kaneka Corporation (4118.T)
Tokai Carbon Co., Ltd. (5301.T)
Ester Industries Limited (ESTER.NS)
Zeon Corporation (ZEOOF)
Business
Iofina plc is a vertically integrated holding company focused on the exploration, production and extraction of iodine from brine streams in oil and gas operations and the manufacture of specialty halogen-based chemical derivatives; it identifies, develops, builds, owns and operates iodine extraction plants using its proprietary WET IOsorb technology across multiple facilities, primarily in Oklahoma, with iodine production vertically integrated into derivatives produced at its Kentucky facility. The company, founded in 2005 and headquartered at 48 Chancery Lane in London, United Kingdom, with key US operations through subsidiaries Iofina Resources in Oklahoma and Iofina Chemical in Covington, Kentucky, ranks as the second-largest iodine producer in North America and serves global markets including pharmaceuticals, biocides, animal health, nutrition, agrochemicals, electronics, semiconductors, food and beverage, personal care, paints, coatings and dairy via crystalline iodine, prilled iodine, iodine derivatives such as IPBC (a specialty fungicide and preservative), hydriodic acid (used in acetic acid manufacturing and animal health) and a new animal feed additive launched in early 2025, alongside non-iodine halogen-based products like biocides, disinfectants, sanitizers, odor controllers, catalysts and intermediates. Operations span northwest and central Oklahoma with eight IOsorb plants, five in the northwest and three recent additions in the central region, extracting iodine from otherwise wasted produced water brine to minimize environmental impact while targeting markets reliant on stable iodine supply amid growing demand for medical contrast media, LCD screens and biocides. Recent developments include the on-time, on-budget completion and commissioning of IO#11 plant in July 2025, adding approximately 100 metric tonnes of annual crystalline iodine production and contributing to record first-half 2025 output of 305.5 metric tonnes from seven plants alongside 12% sales growth to $29.2 million driven by 22% higher iodine sales and robust pricing above $70 per kilogram; IO#12 negotiations advanced to final stages with foundation work and construction expected by year-end 2025; strategic expansion of crystalline iodine customer base; receipt of $1.8 million in US Employee Retention Tax Credits in July-August 2025; addition of new animal feed product boosting derivatives sales; facility upgrades at Iofina Chemical including programmable logic controls, a new reaction vessel, iodine delivery systems and storage capacity; appointment of Ambrian Partners as joint broker in 2024; and launch of a new company website in May 2024, positioning the group for H2 2025 production of 400-440 metric tonnes and sustained growth supported by strong cash generation, banking facilities and favorable iodine market fundamentals.

Company News

APIChatGPT